Cargando…

Can clinical ethics committees be legitimate actors in bedside rationing?

BACKGROUND: Rationing and allocation decisions at the clinical level – bedside rationing – entail complex dilemmas that clinicians and managers often find difficult to handle. There is a lack of mechanisms and aids for promoting fair decisions, especially in hard cases. Reports indicate that clinica...

Descripción completa

Detalles Bibliográficos
Autores principales: Magelssen, Morten, Bærøe, Kristine
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6923892/
https://www.ncbi.nlm.nih.gov/pubmed/31856803
http://dx.doi.org/10.1186/s12910-019-0438-y
_version_ 1783481615418130432
author Magelssen, Morten
Bærøe, Kristine
author_facet Magelssen, Morten
Bærøe, Kristine
author_sort Magelssen, Morten
collection PubMed
description BACKGROUND: Rationing and allocation decisions at the clinical level – bedside rationing – entail complex dilemmas that clinicians and managers often find difficult to handle. There is a lack of mechanisms and aids for promoting fair decisions, especially in hard cases. Reports indicate that clinical ethics committees (CECs) sometimes handle cases that involve bedside rationing dilemmas. Can CECs have a legitimate role to play in bedside rationing? MAIN TEXT: Aided by two frameworks for legitimate priority setting, we discuss how CECs can contribute to enhanced epistemic, procedural and political legitimacy in bedside rationing decisions. Drawing on previous work we present brief case vignettes and outline several potential roles that CECs may play, and then discuss whether these might contribute to rationing decisions becoming legitimate. In the process, key prerequisites for such legitimacy are identified. Legitimacy places demands on aspects such as the CEC’s deliberation process, the involvement of stakeholders, transparency of process, the opportunity to appeal decisions, and the competence of CEC members. On these conditions, CECs can help strengthen the legitimacy of some of the rationing decisions clinicians and managers have to make. CONCLUSIONS: On specified conditions, CECs can have a well-justified advisory role to play in order to enhance the legitimacy of bedside rationing decisions.
format Online
Article
Text
id pubmed-6923892
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-69238922019-12-30 Can clinical ethics committees be legitimate actors in bedside rationing? Magelssen, Morten Bærøe, Kristine BMC Med Ethics Debate BACKGROUND: Rationing and allocation decisions at the clinical level – bedside rationing – entail complex dilemmas that clinicians and managers often find difficult to handle. There is a lack of mechanisms and aids for promoting fair decisions, especially in hard cases. Reports indicate that clinical ethics committees (CECs) sometimes handle cases that involve bedside rationing dilemmas. Can CECs have a legitimate role to play in bedside rationing? MAIN TEXT: Aided by two frameworks for legitimate priority setting, we discuss how CECs can contribute to enhanced epistemic, procedural and political legitimacy in bedside rationing decisions. Drawing on previous work we present brief case vignettes and outline several potential roles that CECs may play, and then discuss whether these might contribute to rationing decisions becoming legitimate. In the process, key prerequisites for such legitimacy are identified. Legitimacy places demands on aspects such as the CEC’s deliberation process, the involvement of stakeholders, transparency of process, the opportunity to appeal decisions, and the competence of CEC members. On these conditions, CECs can help strengthen the legitimacy of some of the rationing decisions clinicians and managers have to make. CONCLUSIONS: On specified conditions, CECs can have a well-justified advisory role to play in order to enhance the legitimacy of bedside rationing decisions. BioMed Central 2019-12-19 /pmc/articles/PMC6923892/ /pubmed/31856803 http://dx.doi.org/10.1186/s12910-019-0438-y Text en © The Author(s). 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Debate
Magelssen, Morten
Bærøe, Kristine
Can clinical ethics committees be legitimate actors in bedside rationing?
title Can clinical ethics committees be legitimate actors in bedside rationing?
title_full Can clinical ethics committees be legitimate actors in bedside rationing?
title_fullStr Can clinical ethics committees be legitimate actors in bedside rationing?
title_full_unstemmed Can clinical ethics committees be legitimate actors in bedside rationing?
title_short Can clinical ethics committees be legitimate actors in bedside rationing?
title_sort can clinical ethics committees be legitimate actors in bedside rationing?
topic Debate
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6923892/
https://www.ncbi.nlm.nih.gov/pubmed/31856803
http://dx.doi.org/10.1186/s12910-019-0438-y
work_keys_str_mv AT magelssenmorten canclinicalethicscommitteesbelegitimateactorsinbedsiderationing
AT bærøekristine canclinicalethicscommitteesbelegitimateactorsinbedsiderationing